Physician profile
Tyler Evans
NPI 1316506249
$1,820.31
in general payments reported to CMS, 2019-2025
24 companies · $972 in 2025
The $972 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $274 · 2024: $574 · 2025: $972.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,748 · Education: $72.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,748.31 |
| Education | $72.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $309.41 | 2023-2025 | Taltz, Ebglyss, Olumiant |
| Abbvie INC. | $252.40 | 2023-2025 | |
| Genzyme Corporation | $212.75 | 2023-2025 | |
| Janssen Biotech, INC. | $158.04 | 2023-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $146.52 | 2023-2025 | Ilumya |
| Incyte Corporation | $119.74 | 2024-2025 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $101.54 | 2024-2025 | Dupixent, Libtayo |
| Novartis Pharmaceuticals Corporation | $87.38 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $62.87 | 2023-2025 | Sotyktu |
| Access Pro Medical, LLC | $48.02 | 2023 | Matriderm |
| Ucb, INC. | $47.77 | 2025 | Bimzelx |
| Galderma Laboratories, L.P. | $35.73 | 2025 | Nemluvio |
| Amgen INC. | $34.74 | 2025 | Otezla |
| Pfizer INC. | $33.80 | 2024 | |
| Exact Sciences Corporation | $31.31 | 2024 | Cologuard Collection Kit |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $19.87 | 2023 | Grafix Pl |
| Lnhc, INC | $16.76 | 2025 | Zelsuvmi |
| Boston Scientific Corporation | $16.02 | 2023 | Watchman Flx |
| Kowa Pharmaceuticals America, INC. | $15.02 | 2025 | Zoryve |
| Ani Pharmaceuticals, INC. | $15.00 | 2025 | Purified Cortrophin Gel |
| Novo Nordisk INC | $14.51 | 2025 | |
| Dermavant Sciences, INC. | $14.42 | 2024 | Vtama |
| Otsuka America Pharmaceutical, INC. | $14.37 | 2024 | Rexulti |
| Organon LLC | $12.32 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.